Lexology November 20, 2024
Holland & Knight LLP

In 2025, Republicans will hold the majority in both chambers of Congress, and the incoming Trump Administration will preside over the executive branch. For healthcare issues at the intersection of access and equity, this trifecta of control will undoubtedly impact both the legislative and regulatory processes, presenting both opportunities and challenges for stakeholders.

Though Republicans will control both chambers of Congress, the margins are slim, with a 218-212 majority in the House and a 53-47 majority in the Senate. For those interested in telehealth, health equity, artificial intelligence (AI) and life sciences, the next few weeks are critical as the contours of a potential end-of-year health package that could include telehealth, reauthorization of the Pediatric Priority Review Voucher program, the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Congress / White House, Digital Health, Equity/SDOH, Govt Agencies, Healthcare System, Pharma, Pharma / Biotech, Technology, Telehealth
What might a Trump administration mean for the Biosecure Act?
A Trump 2.0 Agenda For Artificial Intelligence
InnovationRx: Trump Picks RFK, Jr. And Dr. Oz For Key Healthcare Roles
Lawmakers nix plan for stricter oversight of VA's Oracle EHR rollout
NIH back in the crosshairs

Share This Article